Share on StockTwits

Select Medical Holdings Corporation (NYSE:SEM) was upgraded by Zacks from an “underperform” rating to a “neutral” rating in a research note issued to investors on Monday, reports. The firm currently has a $11.40 price target on the stock. Zacks‘ price target would suggest a potential upside of 2.43% from the stock’s previous close.

Shares of Select Medical Holdings Corporation (NYSE:SEM) traded down 1.35% on Monday, hitting $10.98. The stock had a trading volume of 489,878 shares. Select Medical Holdings Corporation has a 1-year low of $7.21 and a 1-year high of $11.89. The stock’s 50-day moving average is $9.66 and its 200-day moving average is $8.76. The company has a market cap of $1.532 billion and a price-to-earnings ratio of 12.49.

Select Medical Holdings Corporation (NYSE:SEM) last posted its quarterly earnings results on Friday, November 1st. The company reported $0.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.19 by $0.01. The company had revenue of $722.80 million for the quarter, compared to the consensus estimate of $723.10 million. During the same quarter in the previous year, the company posted $0.20 earnings per share. The company’s revenue for the quarter was up 1.3% on a year-over-year basis. Analysts expect that Select Medical Holdings Corporation will post $0.90 EPS for the current fiscal year.

Separately, analysts at Standpoint Research downgraded shares of Select Medical Holdings Corporation from a “buy” rating to a “hold” rating in a research note to investors on Monday, December 23rd. One analyst has rated the stock with a sell rating and six have issued a hold rating to the company’s stock. Select Medical Holdings Corporation has a consensus rating of “Hold” and a consensus target price of $9.60.

Select Medical Holdings Corporation is an operator of both specialty hospitals and outpatient rehabilitation clinics in the United States.

To view Zacks’ full report, visit

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.